Nexvet to present key data on use of species-specific monoclonal antibodies in management of chronic pain in dogs

5th June 2014/in Pharmamark, Portfolio Companies

MELBOURNE, Australia – June 05, 2014 – Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the oral presentation of data related to clinical development of NV-01, a …

Down load article here.